IFM 99-02 Thalidomide in Myeloma

Clinical trial NCT00222053 · COMPLETED

Trial details

NCT number: NCT00222053
Sponsor: University Hospital, Toulouse
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2000-04-01
Primary completion: 2009-09-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.